Meta AnalysisID 4733
尿石素A用于人类抗衰老的系统评价与Meta分析
CRD42022377812
Does urolithin A reduce the severity of age-related physiological changes and the incidence of disease in adults?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4733
- Evidence Id
- 13291
- Core Evidence Id
- 13291
- Source Meta Analysis Id
- 4703
- Herb2 Meta Analysis Id
- HBMA004703
- Crd Id
- CRD42022377812
- Title
- Targeting aging with urolithin A in humans: A systematic review and meta-analysis
- Review Question
- Does urolithin A reduce the severity of age-related physiological changes and the incidence of disease in adults?
- Study Type Included
- Interventional studies independent of methodology will be included. Conference abstracts, clinical study protocols, animal experiments, reviews, editorials, letters to the editor, or book chapters will be excluded.
- Condition Being Studied
- The severity of age-related physiological changes and the incidence of diseases.
- Participant
- Participants with mean or median age of 18 years and above, without an upper age limit.
- Animal
- Human Disease Modelled
- Intervention
- The intervention includes urolithin A with no limit on dosage regimen such as dosage form, dose, dosing interval, treatment duration or route of administration.
- Comparator Control
- Studies with and without controls will be included.
- Main Outcome
- Main outcomes include data on age-related physiological changes or incidence of disease, categorized (but not exclusively) according to the physiological systems identified by the American Physiological Society.
- Outcome Measure
- Additional Outcome
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one; Adult; Aging; Coumarins; Heterocyclic Compounds; Humans; Incidence
- Contact
- Lei Feng [email protected]
- Organisational Affiliation
- NATIONAL UNIVERSITY OF SINGAPORE www.nus.edu.sg
- Funding Source
- National University of Singapore Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> N.A.
- Other Selection Criteria
- Final Publication
- Same Topic Review
- N.A.
- Published Protocol
- Review Type
- Language
- English
- Country
- Singapore
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-11-21
- Registration Date
- 2022-12-02
- Anticipated Start Date
- 2022-11-21
- Anticipated Completion Date
- 2023-06-30
- Title Cn
- 尿石素A用于人类抗衰老的系统评价与Meta分析
- Title En
- Targeting aging with urolithin A in humans: A systematic review and meta-analysis
- Bilingual Status
- complete